Category Archives: News round up

Crohn’s news round up 31st July 2011: Pharma news and win a trip to las Vegas!

IBD Icons launched

American Idol star Casey Abrams is promoting understanding of crohn’s and Colitis as well as offering a fantatsic prize for the ‘IBD icon’ of the year. Read more here:

Remicade/Infliximab has been FDA Approved for use in children. The  FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children. Infliximab, a tumor necrosis factor (TNF) inhibitor, is already approved to treat ulcerative colitis in adults and is also approved to treat Crohn’s disease in both adults and children. Read more here:

Lonza wins contract for bertilimumab(how on earth do you pronounce that?!!!)

Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and manufacturing facility in the UK.

The deal will see the Swiss CMO produce clinical supplies of the antibody in it’s centre in Milton Keynes. Bertilimumab is just about to start a phase II trials programme in inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis.

Bertilimumab is the first monoclonal antibody to specifically neutralise human eotaxin-1, a chemokine associated with inflammatory disease activity.

Read more here:

Crohn’s news round up 03/07/11

Golfer James Morrison was hospitalised with Crohn’s Disease during the French open:

The Daily Mail published an article on British tennis player Elena Baltacha who has primary sclerosing cholangitis (PSC), is a disease of the ducts that channel bile from the liver into the intestines and can also lead to Crohn’s Disease or Ulcerative Colitis:

Abbott Laboratories, who manufacture the anti-inflammatory drug Humira, is looking at ways that it can improve treatment with the drug including a thinner needle and a once a month regime. It is interesting to note that next year Humira,  will become the world’s number one top-selling drug. Find out more at the Wall Street Journal:

Dr Frank Bures at the Winona Daily News comments on the Accutane / IBD debate, suggesting that there is now link between this Acne treatment and IBD:

iCo Therapeutics Inc. has announced that Immune Pharmaceuticals (IMMUNE) has licensed Bertilimumab (iCo-008) for systemic uses. Bertilimumab is a drug which could be useful for Crohn’s and Colitis. Read more here: